top of page
Search
landaulabnyu
- May 23, 2022
- 0 min
4 views0 comments
landaulabnyu
- May 4, 2022
- 0 min
1 view0 comments
landaulabnyu
- May 4, 2022
- 0 min
9 views1 comment
landaulabnyu
- Jan 12, 2022
- 1 min
Omicron Variant has Increased Resistance to Vaccinated Sera and Monoclonal Antibodies
https://www.biorxiv.org/content/10.1101/2021.12.28.474369v1
12 views0 comments
landaulabnyu
- Jan 12, 2022
- 1 min
Our Recent Preprint on Neutralization of Mu and C.1.2 possible VOC
https://www.biorxiv.org/content/10.1101/2021.10.19.463727v1
4 views0 comments
landaulabnyu
- Aug 6, 2021
- 1 min
Forbes speaks about our preprint on vaccine effectiveness
https://www.forbes.com/sites/nicholasreimann/2021/07/20/johnson--johnson-vaccine-far-less-effective-against-delta-variant-study-suggests/...
14 views0 comments
landaulabnyu
- Jul 8, 2021
- 1 min
CBNC News featured our work on the Lamda Variant
https://twitter.com/i/status/1412559070914093056
21 views0 comments
landaulabnyu
- Jul 8, 2021
- 1 min
Medpage Today covered our work on the Lamda Variant
https://www.medpagetoday.com/special-reports/exclusives/93458
6 views0 comments
landaulabnyu
- May 19, 2021
- 1 min
Dr. Anthony Fauci discuss our work on the Indian Variants in the White House Response Team Brief
https://www.youtube.com/watch?v=agaoTSOxDCU
9 views0 comments
landaulabnyu
- May 18, 2021
- 1 min
Featured in Yahoo News for our work on Indian Variant!
https://news.yahoo.com/pfizer-moderna-vaccines-effective-against-171414504.html
12 views0 comments
landaulabnyu
- Apr 23, 2021
- 1 min
Our work on the New york variant was featured in the New York Times!
https://www.nytimes.com/2021/04/22/health/covid-ny-variant-vaccine.html
15 views0 comments
landaulabnyu
- Mar 15, 2021
- 0 min
24 views0 comments
landaulabnyu
- Mar 15, 2021
- 1 min
Our recent work was featured on New Medical Life Sciences
https://www.news-medical.net/news/20210209/Pfizer-BioNTech-COVID-19-vaccine-effective-against-variants-study-shows.aspx
8 views0 comments
landaulabnyu
- Dec 1, 2020
- 1 min
New paper on potential therapy against SARS-CoV-2
Check out our work on the ACE2 microbody as a potent inhibitor of the SARS-CoV-2 virus published in Cell Reports. Congratulations and...
21 views0 comments
landaulabnyu
- Nov 12, 2020
- 2 min
New POSTDOCTORAL POSITIONS in HIV and SARS-CoV-2 Virology and Immunology
https://www.nature.com/naturecareers/job/postdoctoral-position-in-hiv-and-sarscov2-immune-response-and-vaccine-development-nyu-langone-me...
69 views0 comments
landaulabnyu
- Nov 7, 2020
- 1 min
Takuya Tada receives the prestigious Jan T. Vilcek Fellowship in Microbiology!
Congratulations Takuya!
10 views0 comments
landaulabnyu
- Aug 24, 2020
- 1 min
Landau Lab collaborates with Carisma Therapeutics!
CARISMA Therapeutics Inc. now shares the license to use the vpx lentiviral vector created in our lab to facilitate the development of...
48 views0 comments
landaulabnyu
- Jul 17, 2019
- 1 min
Ramanjit Receives Neuroscience Fellowship!
On Monday, the lab celebrated one of our postdoc researchers, Ramajit Kaur, who was one of four recepients of the prestigious Leon Levy...
47 views0 comments
landaulabnyu
- Mar 25, 2019
- 1 min
New Paper in Press!
Lentiviral vector-based dendritic cell vaccine suppresses HIV replication in humanized mice Thomas D. Norton1,2*, Anjie Zhen3*, Takuya...
52 views0 comments
bottom of page